Artia Global Partners »

Ventyx Biosciences shares owned by Artia Global Partners

Quarter-by-quarter ownership of Ventyx Biosciences (VTYX) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Ventyx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Ventyx Biosciences held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ventyx Biosciences by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.3M 696k 9.03

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Proshares Tr Ii Ultra Gold (UGL)
Soleno Therapeutics (SLNO)
Viking Therapeutics (VKTX)
Trevi Therapeutics (TRVI)
Uniqure Nv SHS (QURE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Astrazeneca Sponsored Adr
Cidara Therapeutics Com New (CDTX)
Eyepoint Pharmaceuticals Com New (EYPT)
Ionis Pharmaceuticals (IONS)
Dianthus Therapeutics (DNTH)

View all positions for Artia Global Partners

Top funds holding Ventyx Biosciences

Affinity Asset Advisors
Vanguard Group
BlackRock
Tang Capital Management
Citadel Advisors
Braidwell
Susquehanna International
Millennium Management
MPM Oncology Impact Management
Jane Street
Goldman Sachs Group
Connor, Clark & Lunn Investment Management
Redmile Group
Point72 Asset Management
683 Capital Management

View all funds holding Ventyx Biosciences